{
  "meta": {
    "title": "38_Pediatric_Hematology_-_Introduction_Bleeding_And_Clotting_Disorders",
    "url": "https://brainandscalpel.vercel.app/38-pediatric-hematology-introduction-bleeding-and-clotting-disorders-691646d6.html",
    "scrapedAt": "2025-11-30T12:33:16.021Z"
  },
  "questions": [
    {
      "text": "Which of the following is the predominant site of hematopoiesis in a 20-weeks old fetus?",
      "choices": [
        {
          "id": 1,
          "text": "Yolk sac"
        },
        {
          "id": 2,
          "text": "Liver"
        },
        {
          "id": 3,
          "text": "Spleen"
        },
        {
          "id": 4,
          "text": "Bone marrow"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>liver</strong> is the predominant site of <strong>hematopoiesis</strong> in the fetus during <strong>mid-pregnancy.</strong></p>\n<p>Sites of hematopoiesis:</p>\n<ul>\n<li>2&ndash;6 weeks- yolk sac (mesoblastic phase)</li>\n<li>8&ndash;24 weeks- liver (hepatic phase)</li>\n<li>28 weeks onwards- bone marrow (myeloid phase)</li>\n</ul>\n<p><strong>Note</strong>:</p>\n<p>There is some overlap between the different phases of hematopoiesis. The ranges given above refer to the predominant site of hematopoiesis.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3032",
      "difficulty": "medium"
    },
    {
      "text": "Electrophoresis and globin gene sequencing are performed on a normal embryo's blood sample as a part of hematology research. Which of the following type of hemoglobin is likely to be present?",
      "choices": [
        {
          "id": 1,
          "text": "HbM Iwate"
        },
        {
          "id": 2,
          "text": "Hb Portland"
        },
        {
          "id": 3,
          "text": "Hb Auckland"
        },
        {
          "id": 4,
          "text": "HbM Boston"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hb Portland</strong> is likely to be present as it is <strong>embryonic hemoglobin.&nbsp;</strong></p>\n<p><br /><strong>Gower-I </strong>(&zeta;<sub>2</sub>&epsilon;<sub>2</sub>),<strong> Gower-II</strong> (&alpha;<sub>2</sub>&epsilon;<sub>2</sub>), and<strong> Hb Portland&nbsp;</strong>(&zeta;<sub>2</sub>&gamma;<sub>2</sub>) are called <strong>embryonic hemoglobins</strong> and are seen at 8 weeks of intrauterine life.</p>\n<p><strong>HbM&nbsp;Iwate</strong> (option A)<strong>&nbsp;</strong>and <strong>Hb Auckland</strong>&nbsp;(option C)<strong>&nbsp;</strong>and <strong>HbM Boston&nbsp;</strong>(option D)&nbsp;result from globin mutations that stabilize iron in the ferric state, leading to <strong>congenital methemoglobinemia</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3031",
      "difficulty": "medium"
    },
    {
      "text": "When does hemoglobin synthesis switch from HbF to HbA?",
      "choices": [
        {
          "id": 1,
          "text": "At 8 weeks of intrauterine life"
        },
        {
          "id": 2,
          "text": "At 24 weeks of intrauterine life"
        },
        {
          "id": 3,
          "text": "At 38 weeks of intrauterine life"
        },
        {
          "id": 4,
          "text": "At 6 months of postnatal life"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Hemoglobin synthesis <strong>switches</strong> from <strong>HbF</strong> to <strong>HbA</strong> at <strong>38</strong> <strong>weeks</strong> of intrauterine life.</p>\n<p>Hemoglobin types at various periods:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Time</strong></td>\n<td><strong>Major hemoglobin</strong> </td>\n</tr>\n<tr>\n<td>8th week of intrauterine life:</td>\n<td>Embryonic hemoglobins, Gower-1(ζ<sub>2</sub>ε<sub>2</sub>), Gower-2 (α<sub>2</sub>ε<sub>2</sub>), and Portland(ζ<sub>2</sub>γ<sub>2</sub>) are formed</td>\n</tr>\n<tr>\n<td>9th week to birth</td>\n<td>Fetal hemoglobin (HbF) (α<sub>2</sub>γ<sub>2</sub>) is the major hemoglobin</td>\n</tr>\n<tr>\n<td>24th week</td>\n<td>HbF constitutes 90% of the total hemoglobin</td>\n</tr>\n<tr>\n<td> 38 weeks</td>\n<td>The switch to the nearly exclusive synthesis of adult hemoglobin (HbA; α<sub>2</sub>β<sub>2</sub>)</td>\n</tr>\n<tr>\n<td> At birth<br /> </td>\n<td> HbF constitutes 70% of the total hemoglobin</td>\n</tr>\n<tr>\n<td>6 month</td>\n<td> adult pattern HbA &gt; 95%, HbA<sub>2 </sub>&lt; 3.5%, HbF &lt; 2.5%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<ul>\n<li>Chromosome 16 contains alpha (α) gene cluster (3 genes):\n<ul>\n<li>zeta (ζ)</li>\n<li>alpha 1 (α1)</li>\n<li>alpha 2 (α2)</li>\n</ul>\n</li>\n<li>Chromosome 11contains beta (β) gene cluster (5 genes):\n<ul>\n<li>epsilon (ε)</li>\n<li>2 gamma(γ)</li>\n<li>delta (δ)</li>\n<li>beta (β)</li>\n</ul>\n</li>\n</ul>\n<p> </p>\n<p>Changes in globin subunits from embryo to early infancy:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b3c30b1dcb774457a5773f2dbabc43d0x1280x1385.6880733944954.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3030",
      "difficulty": "hard"
    },
    {
      "text": "Hemoglobin fractions were analyzed in a neonate with a family history of sickle cell disease. The test shows elevated levels of fetal hemoglobin (HbF). Which of the following is true about HbF?",
      "choices": [
        {
          "id": 1,
          "text": "HbF accounts for 100% of the total hemoglobin at term."
        },
        {
          "id": 2,
          "text": "HbF is resistant to alkali denaturation."
        },
        {
          "id": 3,
          "text": "HbF has lower affinity for oxygen than HbA."
        },
        {
          "id": 4,
          "text": "HbF has higher affinity for 2,3 bisphosphoglycerate than HbA."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>HbF</strong> is <strong>resistant</strong> to <strong>alkali denaturation.</strong></p>\n<p>Elevated levels of HbF are seen in <strong>sickle cell disease</strong> and<strong> &beta;-thalassemia</strong>, where there is a mutation of the &beta; globin gene. Increased HbF levels persist in childhood and later.&nbsp;</p>\n<p><strong>Properties of fetal hemoglobin (HbF)</strong></p>\n<ul>\n<li>HbF is resistant to alkali denaturation.\n<ul>\n<li>This property forms the basis of the<strong>&nbsp;alkali denaturation test (or Apt test)</strong> to detect the presence of fetal blood in maternal circulation in suspected feto-maternal hemorrhage.</li>\n<li>The&nbsp;<strong>Kleihauer&ndash;Betke test (or acid elution test)</strong> is used to quantitate the amount of feto-maternal hemorrhage to calculate the dosage of anti-D required in Rh-negative mothers.</li>\n</ul>\n</li>\n<li>HBF accounts for <strong>70%</strong> of the hemoglobin at term.\n<ul>\n<li>Increased HbF can be seen in hereditary persistence of fetal hemoglobin, sickle cell anemia, beta-thalassemia, HbC disease, and HbE disease</li>\n</ul>\n</li>\n<li>HbF has a <strong>higher affinity</strong> for oxygen.\n<ul>\n<li>This allows for gas exchange from maternal circulation by binding to oxygen at a relatively low oxygen tension in the maternal blood supplying the chorion.</li>\n</ul>\n</li>\n<li>HbF has <strong>lower&nbsp; affinity for 2,3 bisphosphoglycerate (BPG) than HbA</strong>.\n<ul>\n<li>Lack of interaction between HbF and 2,3 BPG increases the affinity of HbF to oxygen.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p><p>The oxygen dissociation curve for HbF is <strong>shifted to the left&nbsp;</strong>due to increased affinity for oxygen and low 2,3 BPG levels.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3033",
      "difficulty": "medium"
    },
    {
      "text": "You are measuring the life span of RBCs in a normal neonate using chromium-labeled erythrocyte studies as a part of a research project under the clinical hematology department. What would be the result?",
      "choices": [
        {
          "id": 1,
          "text": "90-120 days"
        },
        {
          "id": 2,
          "text": "60-90 days"
        },
        {
          "id": 3,
          "text": "45-60 days"
        },
        {
          "id": 4,
          "text": "30-45 days"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The lifespan of <strong>neonatal RBCs</strong> is <strong>60-90 days</strong>.</p>\n<p>The short lifespan of neonatal RBCs is the cause for rapid fall in hematocrit immediately after birth. The&nbsp;highest hematocrit during a person&rsquo;s lifetime occurs at birth, and the lowest occurs about 10 weeks later.&nbsp;</p>\n<p>The lifespan of RBCs in preterm infants is <strong>35-50</strong> days.</p>\n<p>The average lifespan of RBCs in adults is <strong>120</strong> days.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3062",
      "difficulty": "medium"
    },
    {
      "text": "A concerned mother brings her preschool child to you. She states that her child was fine until yesterday night and now is covered with bruises and purple dots, which she had noticed while changing his clothes in the morning. She informs you that one month back, her child had a cough and cold. Findings on physical examination are normal, other than petechiae and purpura. Which of the following is most likely to be seen while investigating this child?",
      "choices": [
        {
          "id": 1,
          "text": "Normal platelet count"
        },
        {
          "id": 2,
          "text": "Prolonged prothrombin time"
        },
        {
          "id": 3,
          "text": "Prolonged activated partial thromboplastin time"
        },
        {
          "id": 4,
          "text": "Prolonged bleeding time"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An otherwise <strong>well-baby</strong> with acute onset of <strong>petechiae and purpura</strong> with a preceding <strong>history of viral infection</strong>&nbsp;1 to 4 weeks prior to the onset of thrombocytopenia is a classical presentation of&nbsp;<strong>(autoimmune) idiopathic thrombocytopenic purpura. Prolonged bleeding time</strong> is a feature of ITP.</p>\n<p>The <strong>most common cause</strong> of<strong> acute onset</strong> of <strong>thrombocytopenia</strong> in an otherwise <strong>well-child</strong> is (autoimmune) idiopathic thrombocytopenic purpura (<strong>ITP</strong>).</p>\n<p>ITP is a bleeding disorder and has <strong>prolonged&nbsp;bleeding time, low platelet count, and normal coagulation profile</strong> (prothrombin time [PT] and activated partial thromboplastin time [aPTT]).</p>\n<p>ITP has an acute presentation with a<strong> self-limited course</strong> in children.</p>\n<p>Features of ITP:</p>\n<ul>\n<li>Commonly affects children between 1-4 years&nbsp;</li>\n<li>Preceded by a&nbsp;viral infection</li>\n<li>Mucocutaneous bleeding</li>\n<li>Ecchymoses and petechiae</li>\n<li>Wet purpura (blood blisters in the mouth)</li>\n<li>Retinal hemorrhages</li>\n<li>Bleeding into the CNS, which may be life-threatening</li>\n<li><strong>Hepatomegaly, splenomegaly, and lymphadenopathy, fever, jaundice are absent</strong></li>\n<li>Resolves spontaneously in 80%&nbsp;of the cases in 4-6 weeks.</li>\n</ul>\n<p>Laboratory features of ITP:</p>\n<ul>\n<li>Thrombocytopenia (commonly&nbsp;&lt;20,000/&mu;L)</li>\n<li>Normal/Increased megakaryocytes in bone marrow</li>\n<li>Prolonged bleeding time</li>\n<li>Normal tests for coagulation (PT/aPTT/INR)</li>\n<li>Eosinophilia and lymphocytosis common</li>\n<li>Peripheral smear is normal</li>\n<li>Bone marrow biopsy shows megakaryocytes</li>\n</ul><hr><h3>Related Pearl: Differences between Bleeding Disorders and Coagulation disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Finding</strong></td>\n<td><strong>Bleeding disorders</strong></td>\n<td><strong>Coagulation disorders</strong></td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>\n<p>Quantitative/ Qualitative platelet abnormality</p>\n</td>\n<td>Deficiency of clotting factors</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>More common in females (commonly autoimmune)</td>\n<td>More common in males (commonly X-linked)</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Rare (except in VWD)</td>\n<td>Common</td>\n</tr>\n<tr>\n<td>Petechiae</td>\n<td>Characteristic</td>\n<td>&nbsp;Rare</td>\n</tr>\n<tr>\n<td>Superficial ecchymosis</td>\n<td>Small and Multiple</td>\n<td>Large and Solitary</td>\n</tr>\n<tr>\n<td>Bleeding from superficial cuts&nbsp;</td>\n<td>Profuse</td>\n<td>Minimal persistent</td>\n</tr>\n<tr>\n<td>Hemarthrosis</td>\n<td>Rare</td>\n<td>Characteristic (most common-knee)</td>\n</tr>\n<tr>\n<td>Deep dissecting hematomas</td>\n<td>Rare</td>\n<td>Characteristic (most common-iliopsoas)</td>\n</tr>\n<tr>\n<td>Laboratory tests</td>\n<td>Bleeding time is prolonged</td>\n<td>PT and/or PTT are prolonged</td>\n</tr>\n<tr>\n<td>Most common</td>\n<td>Inherited: VWD</td>\n<td>\n<p>Inherited: Hemophilia A</p>\n<p>Acquired: Hemorrhagic diathesis of liver disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>VWD:&nbsp;von Willebrand disease</p>\n<p>PT: Prothrombin time</p>\n<p>PTT: Partial thromboplastin time</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3145",
      "difficulty": "medium"
    },
    {
      "text": "A pediatrician sees a child in the OPD. He has bruising, petechiae, and occasional minor epistaxis, which has very little interference with his daily activities. Based on further workup, he diagnoses the child as a case of mild ITP. How will he manage this child?",
      "choices": [
        {
          "id": 1,
          "text": "Short course corticosteroid therapy"
        },
        {
          "id": 2,
          "text": "Intravenous anti-D  administration"
        },
        {
          "id": 3,
          "text": "A single dose of intravenous immunoglobulin"
        },
        {
          "id": 4,
          "text": "Education, counseling and watchful expectancy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Other than <strong>education</strong>,<strong>&nbsp;counseling, and watchful expectancy, no therapy&nbsp;</strong>is needed for patients with&nbsp;<strong>mild&nbsp;ITP.&nbsp;</strong></p>\n<p>Classification system for ITP:</p>\n<ol>\n<li>No symptoms.</li>\n<li>Mild symptoms- bruising and petechiae, and occasional minor epistaxis which has very little interference with daily living.</li>\n<li>Moderate symptoms- more severe skin and mucosal lesions, more troublesome epistaxis, and menorrhagia.</li>\n<li>Severe symptoms- bleeding episodes - menorrhagia, epistaxis, and melena - requiring transfusions or hospitalization, symptoms interfering seriously with quality of life.&nbsp;</li>\n</ol>\n<p>Treatment of ITP:</p>\n<ul>\n<li><strong>Mild to moderate</strong> bleeding symptoms- <strong>watchful expectancy, education, and counseling.&nbsp;</strong></li>\n<li><strong>Platelet count &lt; 30,000</strong> <strong>+ risk factors</strong> for bleeding (antiplatelet drugs/anticoagulants or concomitant bleeding disorders)- <strong>oral glucocorticoids</strong>/ intravenous immunoglobulin <strong>(IVIG) or IV anti-D</strong></li>\n<li><strong>Severe</strong> bleeding symptoms-<strong> IV methylprednisolone&nbsp;&plusmn;&nbsp;IVIG or IV anti-D</strong></li>\n<li><strong>Life-threatening&nbsp;bleeding</strong> (eg. intracranial hemorrhage)-<strong> platelet transfusion +&nbsp;IV methylprednisolone +&nbsp;IVIG or IV anti-D</strong></li>\n</ul>\n<p>Note:</p>\n<p>The<strong> role of splenectomy</strong> in ITP should be <strong>reserved for 2 circumstances</strong>:</p>\n<ol>\n<li>The <strong>older child</strong> (&ge;4 yr) with <strong>severe ITP that has lasted &gt;1 year</strong> (chronic ITP) and whose symptoms are <strong>not easily controlled with therapy</strong>&nbsp;</li>\n<li>When<strong> life-threatening hemorrhage</strong> (ICH) complicates acute ITP <strong>and</strong> the <strong>platelet count cannot be corrected rapidly</strong> with transfusion of platelets and administration of IVIG and corticosteroids.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3146",
      "difficulty": "medium"
    },
    {
      "text": "Veena, an adolescent girl has had recurrent episodes of bleeding from her nose and gums. She also gives a history of heavy menstrual bleeding and repeated blood transfusions. Her bleeding time is deranged and flow cytometry reveals markedly decreased CD41 and CD61 expression. A defect in which of the following is most likely seen in her?",
      "choices": [
        {
          "id": 1,
          "text": "Platelet adhesion"
        },
        {
          "id": 2,
          "text": "Platelet activation"
        },
        {
          "id": 3,
          "text": "Platelet aggregation"
        },
        {
          "id": 4,
          "text": "Platelet count"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of<strong> Glanzmann's thrombasthenia</strong>&nbsp;which is characterized by <strong>defective&nbsp;platelet&nbsp;aggregation.</strong></p>\n<p>Decreased <strong>CD41 (GPIIb)</strong> and <strong>CD61 (GPIIIa</strong>) expression are diagnostic of&nbsp;Glanzmann's thrombasthenia. Bleeding in Glanzmann thrombasthenia is quite <strong>severe</strong> and is typically <strong>mucocutaneous</strong>, including epistaxis, gingival, and GI bleeding.</p>\n<p>Bernard-Soulier syndrome and Glanzmann thrombasthenia are severe congenital disorders of platelet function. Patients usually present with petechiae and purpura at birth. The diagnosis is confirmed by <strong>flow cytometric analysis</strong> of the patient&rsquo;s platelet glycoproteins.</p><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3141",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common congenital bleeding disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Hemophilia A"
        },
        {
          "id": 2,
          "text": "Hemophilia B"
        },
        {
          "id": 3,
          "text": "Von Willebrand disease"
        },
        {
          "id": 4,
          "text": "Factor VII deficiency"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Von Willebrand disease </strong>(VWD)<strong>&nbsp;</strong>is the <strong>most common</strong> congenital bleeding disorder.</p>\n<p>VWD is thought to affect approximately 0.1- 1% of the population. It is due to abnormal von Willebrand factor (VWF).</p>\n<p>VWF is an adhesive protein that acts as a bridge between subendothelial collagen and platelets. It also binds and protects the circulating factor VIII from rapid clearance in circulation.</p>\n<p>Von Willebrand disease is mostly inherited as an <strong>autosomal dominant trait</strong> (rarely&nbsp;autosomal recessive). The types of disease include <strong>quantitatively deficient vWF (partial = type 1 or absolute = type 3)</strong> or<strong> qualitatively abnormal vWF (type 2 = dysproteinemia).</strong> The majority (~ 80%) have type 1 disease.&nbsp;</p>\n<p class=\"p1\">Hemophilia A (factor 8 deficiency) occurs in 1 in 5,000 males. Hemophilia B (factor 9 deficiency) occurs in approximately 1 in 25,000 males.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3147",
      "difficulty": "medium"
    },
    {
      "text": "Shortly after birth through normal vaginal delivery, a neonate develops petechiae and purpura. You suspect bleeding disorder and send samples for further workup. A prolonged bleeding time, normal platelet count, normal aPTT is seen along with large platelets in the peripheral smear. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Bernard-Soulier syndrome"
        },
        {
          "id": 2,
          "text": "Glanzmann's thrombasthenia"
        },
        {
          "id": 3,
          "text": "von Willebrand disease"
        },
        {
          "id": 4,
          "text": "Evans syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Bernard–Soulier syndrome</strong> is the likely diagnosis in the given clinical scenario.</p>\n<p>The presence of <strong>petechiae</strong> and <strong>purpura</strong> at <strong>birth,</strong> especially after <strong>vaginal delivery,</strong> along with<strong> prolonged bleeding time</strong>, normal platelet count, normal aPTT are seen in <strong>qualitative platelet defect disorders</strong> like Bernard-Soulier syndrome and Glanzmann's thrombasthenia.</p>\n<p>The presence of<strong> large platelets</strong> rules out Glanzmann's thrombasthenia. Evans syndrome is an autoimmune hemolytic disorder with thrombocytopenia. Von Willebrand's disease doesn't usually manifest at birth. </p>\n<p>Bernard–Soulier syndrome is an autosomal recessive functional/qualitative platelet disorder. It is characterized by the <strong>deficiency of</strong> <strong>Gp Ib-IX receptor</strong> causing defective platelet adhesion. It is due to genetic mutations in the genes forming the GPIb complex of glycoproteins Ibα, Ibβ, V, and IX.</p>\n<p>Laboratory parameters:</p>\n<ul>\n<li>Normal platelet count (or mild thrombocytopenia)</li>\n<li>Large platelets (megathrombocytes) with dense granules</li>\n<li>Bleeding time abnormally prolonged</li>\n<li>Platelet aggregation tests are normal (with collagen, adenosine diphosphate [ADP], epinephrine)</li>\n<li>Ristocetin aggregation test is abnormal/no response</li>\n<li>von Willebrand factor (vWF) levels are normal.</li>\n</ul><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3258",
      "difficulty": "medium"
    },
    {
      "text": "A panicked father brings his adopted daughter to your OPD with complaints of bleeding gums. Hematological investigations reveal a normal platelet count and a prolonged bleeding time. The ristocetin-aggregation test was abnormal. Which of the following would you include in your differential diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "von Willebrand disease"
        },
        {
          "id": 2,
          "text": "Bernard-Soulier syndrome"
        },
        {
          "id": 3,
          "text": "Glanzmann thrombasthenia"
        },
        {
          "id": 4,
          "text": "Both A and B"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The<strong> ristocetin-aggregation</strong> test is <strong>abnormal </strong>in both<strong> von Willebrand disease</strong> and <strong>Bernard–Soulier syndrome.</strong></p>\n<p>All of the above diseases are inherited bleeding disorders affecting <strong>platelet function</strong>. Hence, there is<strong> prolonged bleeding time</strong> but platelet levels are not significantly affected. </p>\n<p>Platelet aggregation tests use a panel of platelet agonists (adenosine diphosphate [ADP], epinephrine, collagen, and ristocetin) to measure platelet activation and aggregation in vitro.</p>\n<p><strong>Ristocetin induces</strong> the <strong>binding of VWF to platelets</strong> and agglutinates platelets.</p>\n<p>Bernard-Soulier syndrome, a severe congenital platelet function disorder, is caused by an absence or severe deficiency of the VWF receptor on the platelet membrane. Hence, in <strong>Bernard–Soulier syndrome,</strong> <strong>no response</strong> (or no aggregation) is seen with ristocetin.</p>\n<p>The<strong> ristocetin-aggregation</strong> test is also <strong>abnormal</strong> in <strong>von Willebrand disease</strong>. However, it <strong>normalizes</strong> after the addition of normal <strong>plasma</strong> (which contains vWF) since there is no defect in binding receptors.</p><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3257",
      "difficulty": "medium"
    },
    {
      "text": "An ENT surgeon refers a child who had developed prolonged bleeding post-tonsillectomy to the hematology department for evaluation. Workup revealed a qualitative defect in the von Willebrand factor. Which of the following disease is more likely in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Type 1 Von Willebrand disease"
        },
        {
          "id": 2,
          "text": "Type 2 Von Willebrand disease"
        },
        {
          "id": 3,
          "text": "Type 3 Von Willebrand disease"
        },
        {
          "id": 4,
          "text": "Type 4 Von Willebrand disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of<strong> von Willebrand disease&nbsp;</strong>(VWD) and a&nbsp;<strong>qualitative defect</strong> in von Willebrand factor (VWF) is seen in <strong>type 2</strong> <strong>VWD</strong>.</p>\n<p>Features of VWD:</p>\n<ul>\n<li>Most common type is Type 1</li>\n<li>Most severe type is Type&nbsp;3</li>\n<li>Most common inheritance: Autosomal dominant</li>\n<li>Type 1- partial quantitative deficiency of VWF&nbsp;</li>\n<li>Type 2- qualitative deficiency of VWF</li>\n<li>Type 3- complete quantitative deficiency of VWF</li>\n</ul>\n<p>There is no type 4&nbsp;VWD.&nbsp;</p>\n<p>Characteristics of the subtypes of VWD are summarized below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Mechanism</strong></td>\n<td><strong>Important characteristics</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>AD</td>\n<td>Partial, quantitative deficiency of VWF</td>\n<td><strong>Most common type</strong></td>\n</tr>\n<tr>\n<td>3</td>\n<td>AR</td>\n<td>Complete quantitative deficiency</td>\n<td>Most severe&nbsp;VWD</td>\n</tr>\n<tr>\n<td>2A</td>\n<td>AD</td>\n<td>Loss of VWF multimers (increased cleavage by ADAMS13)</td>\n<td>Platelet adhesion defect</td>\n</tr>\n<tr>\n<td>2B</td>\n<td>AD</td>\n<td>Increased binding of VWF to platelets causing VWF-platelet complex destruction</td>\n<td><strong>Thrombo-cytopenia</strong></td>\n</tr>\n<tr>\n<td>2M</td>\n<td>AD</td>\n<td>Decreased affinity of VWF to platelets</td>\n<td>Platelet adhesion defect, very rare</td>\n</tr>\n<tr>\n<td>2N</td>\n<td><strong>AR</strong></td>\n<td>Decreased affinity of VWF to Factor VIII</td>\n<td><strong>Autosomal hemophilia</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>AD: autosomal dominant</p>\n<p>AR: autosomal recessive</p><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3252",
      "difficulty": "medium"
    },
    {
      "text": "Which type of von Willebrand disease is associated with thrombocytopenia?",
      "choices": [
        {
          "id": 1,
          "text": "Type 2M"
        },
        {
          "id": 2,
          "text": "Type 2N"
        },
        {
          "id": 3,
          "text": "Type 2A"
        },
        {
          "id": 4,
          "text": "Type 2B"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>von Willebrand disease associated with <strong>thrombocytopenia</strong> is&nbsp;<strong>Type 2B</strong>.</p>\n<p><strong>Pseudo-VWD:</strong> VWF is normal, but&nbsp;<strong>platelet</strong> has increased affinity to VWF; it presents in a manner similar to VWD 2B with thrombocytopenia.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Inherit</strong></td>\n<td><strong>Mechanism</strong></td>\n<td><strong>Important characteristics</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>AD</td>\n<td>Partial, quantitative deficiency of VWF</td>\n<td><strong>Most common type</strong></td>\n</tr>\n<tr>\n<td>3</td>\n<td>AR</td>\n<td>Complete quantitative deficiency</td>\n<td>Most severe&nbsp;VWD</td>\n</tr>\n<tr>\n<td>2A</td>\n<td>AD</td>\n<td>Loss of VWF multimers (increased cleavage by ADAMS13)</td>\n<td>Platelet adhesion defect</td>\n</tr>\n<tr>\n<td>2B</td>\n<td>AD</td>\n<td>Increased binding of VWF to platelets causing VWF-platelet complex destruction</td>\n<td><strong>Thrombocytopenia</strong></td>\n</tr>\n<tr>\n<td>2M</td>\n<td>AD</td>\n<td>Decreased affinity of VWF to platelets</td>\n<td>Platelet adhesion defect, very rare</td>\n</tr>\n<tr>\n<td>2N</td>\n<td><strong>AR</strong></td>\n<td>Decreased affinity of VWF to Factor VIII</td>\n<td><strong>Autosomal hemophilia</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3255",
      "difficulty": "hard"
    },
    {
      "text": "A pediatric resident administers 0.5-1 mg of phytonadione intramuscularly to all newborn infants in the ward. Deficiency of which of the following factors is prevented by this medication?",
      "choices": [
        {
          "id": 1,
          "text": "Factor V"
        },
        {
          "id": 2,
          "text": "Factor VII"
        },
        {
          "id": 3,
          "text": "Factor VIII"
        },
        {
          "id": 4,
          "text": "Factor XI"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Intramuscular injection of 0.5-1 mg of&nbsp;<strong>phytonadione</strong> is given to all <strong>newborn</strong> infants because it prevents the deficiency of<strong> factor VII </strong>that occurs transiently after birth.</p>\n<p><strong>Hemorrhagic disease of the newborn</strong> is caused by a&nbsp;transient deficiency of <strong>vitamin K</strong>&ndash;dependent factors,<strong>&nbsp;factors II, VII, IX, and X.</strong></p>\n<p>Causes include:</p>\n<ul>\n<li>Lack of free vitamin K from the mother</li>\n<li>Absence of the bacterial intestinal flora normally responsible for the synthesis of vitamin K.</li>\n</ul>\n<p>It is responsive to and prevented by vitamin K therapy (0.5-1 mg of phytonadione).</p><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3144",
      "difficulty": "medium"
    },
    {
      "text": "The most common bleeding manifestation seen in severe hemophilia is _____________.",
      "choices": [
        {
          "id": 1,
          "text": "Recurrent hematomas"
        },
        {
          "id": 2,
          "text": "Recurrent hemarthrosis"
        },
        {
          "id": 3,
          "text": "Hematuria"
        },
        {
          "id": 4,
          "text": "Intracranial hemorrhage"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Recurrent hemarthrosis</strong> is the <strong>most common</strong> bleeding manifestation of <strong>severe</strong> hemophilia.</p>\n<p>Hemophilia is said to be severe when the residual activity of factor VIII is <strong>&lt;1%</strong>.</p>\n<p>Clinical features of hemophilia:</p>\n<ul>\n<li>Clinically, hemophilia A and B are <strong>indistinguishable</strong>.</li>\n<li>It presents early in life- <strong>bleeding after circumcision</strong> or when beginning to walk or crawl.</li>\n<li>Most common bleeding manifestation&nbsp;in severe hemophilia is&nbsp;<strong>recurrent hemarthrosis</strong> and the most common joint affected is the<strong> knee</strong>.</li>\n<li>Acute hemarthrosis- local pain, swelling, and erythema; muscle contractures due to fixed positioning.</li>\n<li>Chronic hemarthrosis- synovial thickening and synovitis in response to intraarticular blood.</li>\n<li>Muscle hematomas can lead to compartment syndromes.</li>\n<li>Hematuria is common but self-limited.</li>\n<li>Life-threatening bleeding- bleeding to oropharyngeal spaces, CNS, and retroperitoneum.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9390",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following factor deficiencies are matched to the correct disease?",
      "choices": [
        {
          "id": 1,
          "text": "Factor V deficiency - Stuart-Prower disease"
        },
        {
          "id": 2,
          "text": "Factor IX deficiency - Parahemophilia"
        },
        {
          "id": 3,
          "text": "Factor X deficiency - Christmas disease"
        },
        {
          "id": 4,
          "text": "Factor XI deficiency - Hemophilia C"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correct match is f<strong>actor XI deficiency and hemophilia C</strong>.</p>\n<p>Clotting factor deficiencies and associated disorders:<br /><br />Factor V&mdash; parahemophilia&nbsp;<br />Factor VIII&mdash; classic hemophilia, hemophilia A<br />Factor IX&mdash; Christmas disease, hemophilia B<br />Factor X&mdash; Stuart-Prower disease<br />Factor XI&mdash; hemophilia C</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3264",
      "difficulty": "medium"
    },
    {
      "text": "Dinesh, a 2-year-old boy presented with a painful left ankle swelling and difficulty walking. In the past, he had presented with significant hematomas at immunization sites. On investigation, he was found to have haemophilia A. What is the treatment of choice in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Cryoprecipitate"
        },
        {
          "id": 2,
          "text": "Fresh frozen plasma"
        },
        {
          "id": 3,
          "text": "Prothrombin complex concentrates (PCCs)"
        },
        {
          "id": 4,
          "text": "Factor VIII concentrate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The treatment of choice for <strong>hemophilia A</strong> is&nbsp;factor replacement therapy<strong>&nbsp;</strong>with <strong>factor VIII concentrate.</strong></p>\n<p><strong>Cryoprecipitate&nbsp;</strong>is used when factor concentrates are not available. Each bag of cryoprecipitate contains 80 IU of factor VIII.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Blood components</strong></td>\n<td><strong>Composition</strong></td>\n<td><strong>Indications</strong></td>\n</tr>\n<tr>\n<td>Factor VIII concentrates</td>\n<td><strong>Factor VIII</strong></td>\n<td><strong>Hemophilia&nbsp;A</strong></td>\n</tr>\n<tr>\n<td>Factor IX concentrates</td>\n<td>Factor IX</td>\n<td>Hemophilia B</td>\n</tr>\n<tr>\n<td>Cryoprecipitate</td>\n<td>\n<p>Fibrinogen</p>\n<p>Factor XIII</p>\n<p>Factor&nbsp;VIII</p>\n<p>von Willebrand factor</p>\n</td>\n<td>\n<p>Fibrinogen deficiency,</p>\n<p>Factor XIII deficiency,</p>\n<p>von Willebrand disease</p>\n</td>\n</tr>\n<tr>\n<td>Fresh Frozen Plasma (FFP)</td>\n<td>\n<p>Coagulation factors</p>\n<p>Protein C</p>\n<p>Protein&nbsp; S</p>\n<p>Antithrombin</p>\n</td>\n<td>\n<p>Deficiency of prothrombin,</p>\n<p>Factor V,</p>\n<p>Factor VII,</p>\n<p>Factor X,</p>\n<p>Factor XI</p>\n</td>\n</tr>\n<tr>\n<td>Prothrombin complex concentrates (PCCs)</td>\n<td>\n<p>Prothrombin</p>\n<p>Factor VII</p>\n<p>Factor IX</p>\n<p>Factor X&nbsp;</p>\n</td>\n<td>\n<p>Deficiency of prothrombin,</p>\n<p>Factor VII,</p>\n<p>Factor X</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3259",
      "difficulty": "medium"
    },
    {
      "text": "A grandmother has noticed that her granddaughter's umbilical stump hasn't fallen off even after 4 weeks. On examination, the pediatrician notices mild bruising. Which of the following clotting factor deficiencies should he suspect?",
      "choices": [
        {
          "id": 1,
          "text": "Factor VII deficiency"
        },
        {
          "id": 2,
          "text": "Factor IX deficiency"
        },
        {
          "id": 3,
          "text": "Factor XI deficiency"
        },
        {
          "id": 4,
          "text": "Factor XIII deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Delayed separation</strong> of the umbilical stump&nbsp;beyond 4 weeks is a characteristic finding seen in&nbsp;<strong>factor XIII deficiency.</strong> However, these findings can also be seen in septicemia or local infections.</p>\n<p><strong>Factor XIII</strong> is responsible for the <strong>crosslinking of fibrin to stabilize</strong> the fibrin clot, symptoms&nbsp;of delayed hemorrhage are secondary to the instability of the clot. Typically, patients have trauma one day and then have a bruise or hematoma the next day.</p>\n<p>Results of the<strong>&nbsp;usual screening tests for hemostasis</strong> are <strong>normal</strong> in patients with factor XIII deficiency. Screening tests for factor XIII deficiency are based on the observation that there is increased solubility of the clot because of the failure of cross-linking.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3115",
      "difficulty": "medium"
    }
  ]
}